At #ASCPT2024, see a pharmacogenomic analysis assessing the PK endpoints from a drug-drug interaction study of a TKI combination using the Inje cocktail in patients with BRAF V600-mutant advanced melanoma or other advanced solid tumors. PII-083 bit.ly/3TEbrQ6
0
0
3
487
0
Download Image